widely available market price
(5) Widely available market price (A) In general In this subsection, the term “widely available market price” means the price that a prudent physician or supplier would pay for the drug or biological. In determining such price, the Inspector General shall take into account the discounts, rebates, and other price concessions routinely made available to such prudent physicians or suppliers for such drugs or biologicals. (B) Considerations In determining the price under subparagraph (A), the Inspector General shall consider information from one or more of the following sources: (i) Manufacturers. (ii) Wholesalers. (iii) Distributors. (iv) Physician supply houses. (v) Specialty pharmacies. (vi) Group purchasing arrangements. (vii) Surveys of physicians. (viii) Surveys of suppliers. (ix) Information on such market prices from insurers. (x) Information on such market prices from private health plans.